(Q43122802)

English

No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group

scientific article published on 19 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

phase II clinical trial

0 references

German Hodgkin Study Group

13

object named as

German Hodgkin Study Group

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

K Behringer

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

L Wildt

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

H Mueller

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

V Mattle

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

P Ganitis

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

B van den Hoonaard

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

H W Ott

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

S Hofer

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

A Pluetschow

9

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

V Diehl

10

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

A Engert

11

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

P Borchmann

12

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

19 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

2052-2060

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Treatment-related risk factors for premature menopause following Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Failure to preserve fertility in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Anti-mullerian hormone as a marker of ovarian reserve

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Relationship of serum antimüllerian hormone concentration to age at menopause

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Anti-Müllerian hormone: a new marker for ovarian function

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Early menopause in long-term survivors of cancer during adolescence

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Livebirth after orthotopic transplantation of cryopreserved ovarian tissue

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ066

21 January 2018

Identifiers

10.1093/ANNONC/MDQ066

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43122802&oldid=1597771368"